MFDS — authorised 7 April 1986
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
🇰🇷 Clindamycin 2-Palmitate in South Korea
MFDS authorised Clindamycin 2-Palmitate on 7 April 1986
Marketing authorisation
Clindamycin 2-Palmitate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Clindamycin 2-Palmitate approved in South Korea?
Yes. MFDS authorised it on 7 April 1986.
Who is the marketing authorisation holder for Clindamycin 2-Palmitate in South Korea?
PHARMACIA AND UPJOHN holds the South Korean marketing authorisation.